Ipoh's Hospital Raja Permaisuri Bainun says Malaysia must treat obesity as a chronic disease like advanced nations
Recognised as the gold standard for weight loss treatment, bariatric surgery is not only helping patients shed excess weight but also improving their overall health and life expectancy.
One of the hospital's standout offerings is the Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy (SADI-S), an innovative weight-loss procedure that combines elements of sleeve gastrectomy and gastric bypass.
Practiced at HRPB since April last year, SADI-S has already demonstrated remarkable success.
'SADI-S combines the best aspects of sleeve gastrectomy and gastric bypass, offering sustainable weight loss and remission of obesity-related conditions like diabetes and hypertension without significant side effects,' explained Dr. S. Kumaresan, Consultant General, Bariatric and OesophagoGastric Surgery.
With six successful surgeries conducted, patients have reported dramatic results, including losing up to 80 per cent of their excess weight within a year.
The procedure, however, is only recommended for individuals meeting strict criteria, such as those with a BMI over 45 or conditions like diabetes, hypertension, or sleep apnea. Patients must also commit to a high-protein diet and lifelong dietary monitoring and supplements.
'This is not just about weight loss—it's about transforming lives,' added Dr. Kumaresan.
Patient story
One such success story is Sharul Nizam Kamal, a 38-year-old who underwent SADI-S surgery.
Sharul initially weighed 185 kg and has since lost an impressive 60 kg, bringing his weight down to 125 kg. 'I'm incredibly happy with the results,' Sharul said, expressing his gratitude to the doctors.
'This surgery has not only improved my health but also given me a new lease on life. I feel healthier, more energetic, and I can do so much more now—things I never imagined I could before.'
Comprehensive care and accessibility
HRPB adopts a holistic, multidisciplinary approach, assembling a dedicated team of surgeons, endocrinologists, dietitians, psychiatrists, pharmacists, respiratory physicians, and anaesthetists.
'We want our patients to see every necessary specialist and go home safely after the procedure,' said Dr. V. Rama Moorthy from the same department.
Cost is another critical factor, with public hospitals like HRPB offering bariatric surgery at a significantly lower price than private facilities.
The process, from the initial consultation to surgery, typically takes three to six months, ensuring patients are thoroughly prepared for the procedure and recovery.
Doctors at Hospital Raja Permaisuri Bainun perform a bariatric surgery procedure. Committed to improving outcomes, HRPB's team actively participates in international workshops and recently hosted surgeons from Australia and Thailand for a SADI-S workshop to enhance expertise. — Picture courtesy of Hospital Raja Permaisuri Bainun
Raising awareness amid challenges
Malaysia has the highest obesity rates in Southeast Asia, with one in two adults overweight. Alarmingly, childhood obesity is also on the rise.
Dr. Kumaresan emphasized the importance of treating obesity as a chronic disease. 'It cannot simply be fixed with diet and exercise—it's far more complex, like diabetes or hypertension,' he said.
Unfortunately, misconceptions and stigma surrounding bariatric surgery remain barriers to treatment.
Many people perceive the procedure as an 'easy way out,' undermining its significance as a medically managed intervention.
'The stigma is one of our biggest challenges,' Dr. Kumaresan explained.
'Some patients hesitate to seek help because they fear being judged by family, friends, or even healthcare professionals. It's disheartening when people don't realise that this surgery could save lives.'
Even within the medical community, misconceptions persist. 'Some doctors and surgeons still view bariatric surgery as mutilative or unnecessary.'
'This highlights the need for continued education and awareness, sharing of the latest evidence-based practices globally among healthcare providers.'
The stigma also extends to patients themselves, with many experiencing feelings of isolation or guilt.
'Patients often tell us they've faced years of criticism for their weight, and it can take a significant emotional toll,' Dr. Kumaresan shared.
'When they finally undergo surgery and see the results, the relief and joy are immeasurable—not just physically, but mentally and emotionally.'
Expertise and collaboration
HRPB's doctors are committed to raising awareness and improving outcomes. They frequently attend international workshops and conferences to exchange knowledge and discuss challenges.
Recently, the hospital hosted Australian and Thailand surgeons for a workshop on SADI-S, further enhancing their expertise.
'By collaborating and sharing experiences, we continue to improve outcomes for our patients,' said Dr. Kumaresan.
For those struggling with obesity, HRPB's bariatric clinic offers hope and a chance for a healthier future.
'Seeing patients regain their health and confidence is incredibly rewarding,' said Dr. Rama.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Why UnitedHealth Stock Is Skyrocketing Today (Hint: Warren Buffett)
Key Points Berkshire Hathaway's latest SEC filing revealed that the company has taken a $1.6 billion stake in UnitedHealth Group. Berkshire added a few others while reducing stakes in both Apple and Bank of America. UnitedHealth has faced several challenges this year, including the revelation of multiple DOJ investigations and the resignation of its CEO. 10 stocks we like better than UnitedHealth Group › Shares of UnitedHealth Group (NYSE: UNH) are jumping on Friday, up 13.8% as of 2:14 p.m. ET. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) declined 0.1% and the Nasdaq Composite (NASDAQINDEX: ^IXIC) fell 0.3%. The troubled health insurance giant is finally seeing its stock rebound after months of trouble, thanks to the purchase of 5 million shares by Warren Buffett's Berkshire Hathaway. Berkshire buys UNH Berkshire Hathaway's latest regulatory filing revealed that the company took a considerable stake in UnitedHealth. The 5 million-share, $1.6 billion stake makes the massive health insurer the 18th-biggest position in Berkshire's portfolio. Buffett's company also trimmed its positions in Apple and Bank of America. The move took Wall Street by surprise, given the many issues UnitedHealth faces, and the revelation sent shares soaring immediately. UnitedHealth is struggling The company's most recent quarterly report revealed a darkening financial picture, including a significant miss on earnings per share, as costs from medical care continue to balloon. The company was also forced to suspend guidance as it tries to adapt to the shifting market. Its financial woes are far from the company's only issues, having recently suffered the sudden departure of its CEO for "personal reasons." The departure comes as the company faces two Department of Justice (DOJ) probes -- one criminal and one civil -- into its Medicare billing practices. Buyer beware It's hard to disagree with the Oracle of Omaha, but there are just too many issues facing UnitedHealth at the moment and with no clear picture of an imminent turnaround. I would stay away from the stock. Should you invest $1,000 in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Bank of America is an advertising partner of Motley Fool Money. Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple and Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Why UnitedHealth Stock Is Skyrocketing Today (Hint: Warren Buffett) was originally published by The Motley Fool
Yahoo
a day ago
- Yahoo
Warren Buffett's company reveals new investments in Nucor, UnitedHealth and two big homebuilders
OMAHA, Neb. (AP) — Berkshire Hathaway revealed four new investments Thursday in steelmaker Nucor, insurer UnitedHealth and two of the nation's biggest homebuilders — Lennar and DR Horton — but it's not clear if the investments are big enough to ensure that legendary investor Warren Buffett handled them. Buffett, who plans to retire as CEO at the end of the year after six decades of building Berkshire, handles all of the conglomerate's biggest investments worth $1 billion or more. Three of the new investments disclosed Thursday in a filing with the Securities and Exchange Commission are worth less than that, so they could be the ideas of one of Berkshire's two other investment managers. But Berkshire's new UnitedHealth stake that was also revealed Thursday was worth $1.57 billion, so that one could be big enough to be Buffett's handiwork. Berkshire got permission from the SEC to keep the other three investments confidential earlier this year while it built those stakes, but it apparently bought nearly 5 million UnitedHealth shares just in the second quarter. That stock jumped nearly 8% in aftermarket trading. Berkshire's filings simply offer a snapshot of its $258 billion portfolio at the end of the second quarters. Many investors comb through Berkshire's filings every quarter because they like to follow Buffett's moves. His record of trouncing the S&P 500 for decades has inspired legions of followers. The filing doesn't make clear who at Berkshire handled each investment. Besides Buffett, Ted Weschler and Todd Combs also pick stocks, but they generally handle smaller portfolios and Combs also serves as Geico's CEO. But Buffett has had a hard time finding stocks or any other investments in recent years that he wants to invest much of Berkshire's $344 billion cash in. Berkshire's Nucor stake of 6.6 million shares was the biggest new investment worth roughly $857 million at the end of the quarter. Shares of that company rose more than 6% in extended after-hours trading. The Lennar investment was worth nearly $800 million. While the DR Horton stake was much smaller worth $191.5 million. Those companies' stocks also saw gains in late trading Buffett already knows quite a lot about the home building business because Berkshire owns the nation's largest manufactured homebuilder, Clayton Homes. Besides stocks, Berkshire owns dozens of companies in a variety of industries including Geico insurance, BNSF railroad, several major utilities and an assortment of manufacturing and retail companies. The Omaha, Nebraska-based company's holdings include many well-known brands like See's Candy and Dairy Queen. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNBC
a day ago
- CNBC
Why Warren Buffett and other top investors may find troubled UnitedHealth appealing right now
UnitedHealth shares are getting a much needed boost after high-profile investors including Warren Buffett and David Tepper unveiled new stakes in the scandal-plagued insurer. The health care stock popped 10% on Friday, on track for its best day in five years. The advance came after Buffett's conglomerate Berkshire Hathaway revealed a stake of five million shares , worth about $1.6 billion. The "Big Short" investor Michael Burry and Appaloosa Management's Tepper also disclosed sizable stakes in the company. It may come as a surprising move as UnitedHealthcare has become the poster child for problems with the nation's sprawling health-care system. The company recently suffered a string of setbacks , including a suspension of 2025 guidance , the abrupt departure of former CEO Andrew Witty and a Justice Department investigation into its Medicare billing practices. So, why are these top investors buying now? 50% off One unquestionable factor is just how cheap the stock has become. At its peak just nine months ago, shares closed at $615, topping a market capitalization of $500 billion. The stock has now been cut more than half, a rare occurrence for a blue-chip, household name that has been a member of the coveted Dow Jones industrial Average since 2012. "It is available now at a 50% discount. It will probably pay major fines and some executives may be forced to leave the company. But the company will survive and likely regain its prominence in the industry," said David Kass, a finance professor at the University of Maryland who has studied Buffett's methods for a long time. "Its finances are solid. It has above average profitability and a below average price to earnings ratio." UNH 1Y bar UnitedHealth in the past 1-year period Shares of the insurer traded at a price-earnings ratio of just under 12 Thursday, near its lowest in more than a decade. That compared to a 10-year average multiple of 23, according to FactSet data. The healthcare sector is the worst performer among the 11 S & P 500 groupings this year, down nearly 3% as of Thursday's close. "The sector has been under-loved and undervalued for a while," Robert Teeter, chief investment strategist at Silvercrest Asset Management, said on CNBC's "Worldwide Exchange" Friday. "You get some investors that are willing to step in and that creates a sense of momentum. It's an area that has a lot of potential for margin recovery." 'Surmountable' woes? Buffett has a history and reputation of avoiding conflict and controversy when it comes to investing. The last and perhaps the only time Berkshire had an investment embroiled in controversies was Wells Fargo , which conducted fraudulent practices that came to light in 2016. Buffett exited the position 2022. Berkshire's UnitedHealth bet is also an unlikely one given Buffett's longtime distain towards the industry. He previously called the healthcare industry a "tapeworm" on the economy due to its high costs. In 2018, he, along with Jeff Bezos and Jamie Dimon , launched a joint venture to improve health care for their employees and potentially for all Americans, but it was eventually shut down. Still, Buffett's primary focus is always on understanding the business itself, the cost and its long-term potential. Berkshire, with a gigantic footprint in the broader insurance industry, may have special insight into the health insurer. "UNH sports an undeniably cheap valuation but it comes under the cloud of a government investigation and questions about reimbursement levels," said Bill Stone, Glenview Trust Company CIO and a longtime Berkshire shareholder. "Buffett is always interested in strong franchises that he thinks are dealing with surmountable short-term woes and that could be his view here." Long time horizon The size of Berkshire's stake — $1.5 billion — indicated to some that Buffett's two investing lieutenants, Todd Combs and Ted Weschler, were more responsible for this purchase rather than the "Oracle of Omaha" himself. Though, it's probable that Buffett and incoming CEO Greg Abel blessed this move. What sets Berkshire apart from others is its buy-and-hold long-term approach, which could work to its advantage as UnitedHealth seeks to avert its crisis and regain public trust, according to George Hill, a healthcare analyst at Deutsche Bank. "Berkshire clearly has the one attribute many investors do not have, which is duration," Hill said in a note to clients. "While we believe that UNH shares appear attractively valued on a three-plus year time horizon, UNH's next two years could be very choppy from a membership, reimbursement and profitability perspective." UnitedHealth owns the nation's largest and most powerful insurer, UnitedHealthcare, and is often viewed as the industry's bellwether. Wall Street analysts have welcomed with the return of Stephen Hemsley to lead the company again. Hemsley is widely credited as the CEO who transformed the company into the conglomerate it is today. UnitedHealth's 2024 was a particularly tough one. It grappled with the murder of the UnitedHealthcare unit's CEO, Brian Thompson, the torrent of public blowback that followed and a historic cyberattack that affected millions of Americans.